These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11728631)

  • 1. A high density lipoprotein from Piaractus mesopotamicus, pacu, (Osteichthyes, Characidae), is associated with paraoxonase activity.
    Folly E; Bastos VL; Alves MV; Bastos JC; Atella GC
    Biochimie; 2001 Oct; 83(10):945-51. PubMed ID: 11728631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.
    Mackness MI; Arrol S; Abbott C; Durrington PN
    Atherosclerosis; 1993 Dec; 104(1-2):129-35. PubMed ID: 8141836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein.
    Graham A; Hassall DG; Rafique S; Owen JS
    Atherosclerosis; 1997 Dec; 135(2):193-204. PubMed ID: 9430369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
    Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
    J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine paraoxonase 1 activities in serum and distribution in lipoproteins.
    Miyamoto T; Takahashi Y; Oohashi T; Sato K; Oikawa S
    J Vet Med Sci; 2005 Mar; 67(3):243-8. PubMed ID: 15805725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
    Sanguinetti SM; Brites FD; Fasulo V; Verona J; Elbert A; Wikinski RL; Schreier LE
    Diabetes Nutr Metab; 2001 Feb; 14(1):27-36. PubMed ID: 11345163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids.
    Reddy ST; Wadleigh DJ; Grijalva V; Ng C; Hama S; Gangopadhyay A; Shih DM; Lusis AJ; Navab M; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):542-7. PubMed ID: 11304470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glycation of high density lipoproteins on their physicochemical properties and on paraoxonase activity.
    Ferretti G; Bacchetti T; Marchionni C; Caldarelli L; Curatola G
    Acta Diabetol; 2001 Dec; 38(4):163-9. PubMed ID: 11855794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations.
    Leviev I; Deakin S; James RW
    J Lipid Res; 2001 Apr; 42(4):528-35. PubMed ID: 11290824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation.
    Boemi M; Leviev I; Sirolla C; Pieri C; Marra M; James RW
    Atherosclerosis; 2001 Mar; 155(1):229-35. PubMed ID: 11223446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.
    Watson AD; Berliner JA; Hama SY; La Du BN; Faull KF; Fogelman AM; Navab M
    J Clin Invest; 1995 Dec; 96(6):2882-91. PubMed ID: 8675659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ghrelin can bind to a species of high density lipoprotein associated with paraoxonase.
    Beaumont NJ; Skinner VO; Tan TM; Ramesh BS; Byrne DJ; MacColl GS; Keen JN; Bouloux PM; Mikhailidis DP; Bruckdorfer KR; Vanderpump MP; Srai KS
    J Biol Chem; 2003 Mar; 278(11):8877-80. PubMed ID: 12531885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation.
    Draganov DI; Stetson PL; Watson CE; Billecke SS; La Du BN
    J Biol Chem; 2000 Oct; 275(43):33435-42. PubMed ID: 10931838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exclusive association of paraoxonase 1 with high-density lipoprotein particles in apolipoprotein A-I deficiency.
    Noto H; Hashimoto Y; Satoh H; Hara M; Iso-o N; Togo M; Kimura S; Tsukamoto K
    Biochem Biophys Res Commun; 2001 Nov; 289(2):395-401. PubMed ID: 11716486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation.
    Mackness MI; Arrol S; Mackness B; Durrington PN
    Lancet; 1997 Mar; 349(9055):851-2. PubMed ID: 9121268
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of protection against oxidative modification of LDL by avian HDL.
    Mackness B; Durrington PN; Mackness MI
    Biochem Biophys Res Commun; 1998 Jun; 247(2):443-6. PubMed ID: 9642147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase.
    Blatter MC; James RW; Messmer S; Barja F; Pometta D
    Eur J Biochem; 1993 Feb; 211(3):871-9. PubMed ID: 8382160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of insulin resistance on serum paraoxonase activity in a nondiabetic population.
    Yamada A; Shoji T; Tahara H; Emoto M; Nishizawa Y
    Metabolism; 2001 Jul; 50(7):805-11. PubMed ID: 11436186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor.
    Ahmed Z; Ravandi A; Maguire GF; Emili A; Draganov D; La Du BN; Kuksis A; Connelly PW
    J Biol Chem; 2001 Jul; 276(27):24473-81. PubMed ID: 11320081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification.
    Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN
    FEBS Lett; 1998 Feb; 423(1):57-60. PubMed ID: 9506841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.